Clinical Trials

1,891 enrolled

Breast Neoplasms

NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

40 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT03737695 2026-06-04

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

300 enrolled

Breast Neoplasms

NCT03768492 2026-06-04

ReDCoAT

60 enrolled

Breast Neoplasms

NCT04180579 2026-06-04

Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

34 enrolled

Alopecia, Breast Neoplasms

NCT05870579 2026-06-04

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

48 enrolled

Breast Neoplasms

NCT07626970 2026-06-04

THE EFFECT OF WHATSAPP-BASED EX-PLISSIT MODEL SEXUAL COUNSELING ON SEXUAL FUNCTION AND SEXUAL DISTRESS IN BREAST CANCER SURVIVORS

86 enrolled

Breast Neoplasms

NCT00903591 2026-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

1,699 enrolled

Breast Neoplasms, Neoplasms

NCT01134172 2026-06-03

Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life

935 enrolled

Breast Neoplasms

NCT02400190 2026-06-03

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

202 enrolled

Breast Neoplasms

NCT02465060 2026-06-03

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellThoracic

6,452 enrolled 1 FDA

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT02927912 2026-06-03

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

108 enrolled 8 charts

Breast Neoplasms

NCT02954874 2026-06-03

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

1,155 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07038369 2026-06-03

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

BreastGenitourinaryGynecologic

134 enrolled

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07624734 2026-06-03

MASTECTAMINE

250 enrolled

Breast Neoplasms

NCT03429907 2026-06-02

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

62 enrolled

Breast Neoplasms

NCT05038735 2026-06-02

EPIK-B5

210 enrolled

Breast Neoplasms

NCT05056077 2026-06-02

TTBF

BreastGastrointestinalGenitourinaryGynecologic

353 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT05787587 2026-06-02

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

216 enrolled

Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related, Breast Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06018337 2026-06-02

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

541 enrolled

Breast Neoplasms

NCT07619781 2026-06-02

Research on the Development and Validation of Personalized Exercise Prescriptions for Breast Cancer Patients Based on Large Language Models

220 enrolled

Breast Neoplasms

NCT02445391 2026-06-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

415 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02810743 2026-06-01

Subito

174 enrolled

Breast Neoplasms

NCT03939897 2026-06-01

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

24 enrolled 15 charts

Breast Neoplasms

NCT05377684 2026-06-01

ROSE

450 enrolled

Breast Neoplasms

NCT05720910 2026-06-01

FRONE

BreastGastrointestinalGenitourinaryThoracic

720 enrolled

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06827132 2026-06-01

CASCADE

600 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT07474090 2026-06-01

STEPS-BC

120 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00310180 2026-05-29

TAILORx

10,273 enrolled 14 charts

Breast Neoplasms

NCT02115282 2026-05-29

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

608 enrolled 18 charts

Breast Neoplasms

NCT02311933 2026-05-29

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

81 enrolled 9 charts

Breast Neoplasms

NCT03697577 2026-05-29

CDK and Body Composition Study

30 enrolled

Breast Neoplasms

NCT04854005 2026-05-29

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

78 enrolled

Breast Neoplasms

NCT05203445 2026-05-29

A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

6 enrolled 9 charts

Breast Neoplasms

NCT06831994 2026-05-29

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

659 enrolled

BreastOther

Arthritis, Rheumatoid, Breast Neoplasms, Coronary Disease, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Obesity, Osteoporosis, Pulmonary Disease, Chronic Obstructive

NCT07601113 2026-05-29

PG2 BEAM-S

66 enrolled

Breast Neoplasms

NCT02883062 2026-05-28

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

67 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03524430 2026-05-28

BREVITY

801 enrolled

Breast Neoplasms

NCT04568616 2026-05-28

NAOMI

178 enrolled

Breast Neoplasms

NCT02568267 2026-05-27

STARTRK-2

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

534 enrolled 1 FDA

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

NCT05088785 2026-05-27

FEStastic

15 enrolled

Breast Neoplasms

NCT07608068 2026-05-27

Performance of Diffusion-weighted Imaging-based Virtual MR Elastography (vMRE) for Diagnosing Breast Cancer

238 enrolled

Breast Neoplasms

NCT06533059 2026-05-26

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

BreastGenitourinaryGynecologic

110 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06772181 2026-05-26

PRO-ACTIVE

40 enrolled

Breast Neoplasms

NCT00585507 2026-05-22

Efficacy and Safety of 500mg of Fulvestrant

40 enrolled